Nath Bio-Genes Share Price | Nath Bio-Genes Stock Screener
NATHBIOGEN
Agricultural Products
Share Price NSE
₹172.20
▲
1.09 (0.64%)
Share Price BSE
₹171.40
▲
0.40 (0.23%)
As of May 27, 2026, the Nath Bio-Genes share price (NSE: NATHBIOGEN) is ₹172.20 on NSE and ₹171.40 on BSE, up 0.64% from the previous close, with shares trading between ₹169.36 and ₹174.89, and a 52-week range of ₹129.02–₹196.01.
Check NATHBIOGEN annual price range for the annual price range and momentum.
Use the Nath Bio-Genes stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Nath Bio-Genes Market Cap
₹334.32 Cr.
NATHBIOGEN P/E Ratio (TTM)
7.84
Nath Bio-Genes P/B Ratio
0.48
EPS (TTM)
₹20.98
Dividend Yield
1.16%
Debt to Equity
0.19
NATHBIOGEN 52 Week High
₹196.01
Nath Bio-Genes 52 Week Low
₹129.02
Operating Margin
9.00%
Profit Margin
-
NATHBIOGEN Revenue (TTM)
₹55.00
EBITDA
₹8.00
Net Income
-
Total Assets
₹1,026.00
Total Equity
₹644.00
Nath Bio-Genes Share Price Chart
Screen Nath Bio-Genes share price with an interactive chart. Analyse NATHBIOGEN price trends and volatility across different timeframes.
Nath Bio-Genes Company Profile - Fundamental Screener
Screen Nath Bio-Genes company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for NATHBIOGEN shares.
Sector
FMCG
Industry
Agricultural Products
Sub-Sector
Agricultural Products
Segment
E
ISIN
INE448G01010
Nath Bio-Genes Balance Sheet Screener
Screen NATHBIOGEN balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Assets | ||||
| Total Assets | 1,026 | 880 | 793 | 740 |
| Current Assets | 690 | 572 | 521 | 468 |
| Fixed Assets | 250 | 250 | 244 | 245 |
| Liabilities | ||||
| Total Liabilities | 0 | 0 | 0 | 0 |
| Current Liabilities | 17 | 8 | 3 | 3 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||
| Total Equity | 644 | 610 | 573 | 542 |
| Share Capital | 19 | 19 | 19 | 19 |
| Reserves & Surplus | 625 | 591 | 554 | 523 |
Nath Bio-Genes Income Statement Screener - Profit & Revenue Analysis
Screen Nath Bio-Genes income statement and profit fundamentals.
Analyze NATHBIOGEN quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Nath Bio-Genes share price evaluation.
| Item | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Dec | 2022-Sept |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 55 | 70 | 48 | 288 | 56 | 37 | 32 | 244 | 44 | 34 | 23 | 235 | 45 | 25 | 22 |
| Expenses | 47 | 62 | 38 | 245 | 52 | 29 | 27 | 207 | 39 | 26 | 18 | 198 | 41 | 20 | 17 |
| EBITDA | 8 | 8 | 10 | 42 | 5 | 9 | 5 | 37 | 5 | 8 | 5 | 37 | 4 | 6 | 5 |
| Operating Profit % | 9.00% | 5.00% | 14.00% | 13.00% | 1.00% | 22.00% | 15.00% | 15.00% | 9.00% | 18.00% | 22.00% | 16.00% | 9.00% | 22.00% | 22.00% |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 5 | 5 | 4 | 3 | 1 | 4 | 3 | 2 | 1 | 3 | 2 | 3 | 2 | 3 | 3 |
| Profit Before Tax | 3 | 3 | 6 | 38 | 2 | 4 | 1 | 34 | 3 | 5 | 2 | 34 | 2 | 2 | 2 |
| Tax | 3 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 0 |
| Net Profit | 0 | 2 | 5 | 37 | 2 | 3 | 1 | 33 | 3 | 4 | 2 | 33 | 1 | 1 | 2 |
| EPS | -0.79 | 0.89 | 2.53 | 19.58 | 0.42 | 1.33 | 0.53 | 17.49 | 1.87 | 2.02 | 0.86 | 17.59 | 0.77 | 0.71 | 0.77 |
Nath Bio-Genes Cash Flow Screener - Liquidity Fundamentals
Screen NATHBIOGEN cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March |
|---|---|---|---|---|
| Operating Activities | 18 | 75 | 38 | 17 |
| Investing Activities | -4 | -27 | -3 | -20 |
| Financing Activities | -2 | -8 | -2 | -22 |
| Net Cash Flow | 12 | 39 | 34 | -25 |
Nath Bio-Genes Shareholding Pattern Screener
See Nath Bio-Genes shareholding pattern with promoter, FII, and DII holdings.
Check Nath Bio-Genes promoter holding and ownership changes for NATHBIOGEN on TickJournal.
| Item | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 45.60% | 45.60% | 45.60% | 45.60% | 45.60% | 45.60% | 45.60% | 45.60% |
| FII Holding | 0.23% | 0.21% | 0.42% | 0.32% | 0.31% | 0.27% | 0.22% | 0.19% |
| DII Holding | 0.01% | 3.94% | 2.25% | 0.76% | 0.01% | 4.37% | 4.38% | 4.37% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 34.39% | 31.94% | 32.98% | 33.78% | 34.22% | 32.25% | 32.43% | 31.54% |
| Other Holding | 19.77% | 18.31% | 18.76% | 19.54% | 19.87% | 17.51% | 17.39% | 18.31% |
| Shareholder Count | 33,031 | 34,911 | 34,207 | 34,122 | 33,550 | 35,132 | 35,834 | 35,423 |
Nath Bio-Genes Share Dividend Screener - Share Yield Analysis
Check Nath Bio-Genes dividend history with payout and yield data.
View Nath Bio-Genes dividend details including ex-dates and amounts for NATHBIOGEN stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹2.00 | 1.55% |
| 2024-March | ₹2.00 | 1.37% |
| 2023-March | ₹2.00 | 1.15% |
| 2022-March | ₹2.00 | 1.43% |
| 2021-March | ₹2.00 | 0.94% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Nath Bio-Genes Stock Index Membership
See which indices include Nath Bio-Genes stock.
Check NATHBIOGEN index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Nath Bio-Genes Market Events Screener - Corporate Actions
Get Nath Bio-Genes corporate actions including splits, bonuses, and buybacks.
Check Nath Bio-Genes stock events that may affect NATHBIOGEN share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-05-04 | 2026-05-04 | Quarterly Result Announcement | NA | 15.33% |
| 2026-01-31 | 2026-01-31 | Quarterly Result Announcement | NA | 2.36% |
| 2025-11-13 | 2025-11-13 | Quarterly Result Announcement | NA | -3.99% |
| 2025-08-22 | 2025-08-22 | Annual General Meeting | NA | 12.38% |
| 2025-08-14 | 2025-08-14 | Dividend | ₹ 2.00 /share | 11.66% |
| 2025-07-11 | 2025-07-11 | Quarterly Result Announcement | NA | 7.96% |
| 2025-04-29 | 2025-04-29 | Quarterly Result Announcement | NA | -6.81% |
| 2025-01-23 | 2025-01-23 | Quarterly Result Announcement | NA | 0.03% |
| 2024-10-23 | 2024-10-23 | Quarterly Result Announcement | NA | -3.86% |
| 2024-08-17 | 2024-08-17 | Annual General Meeting | NA | 8.77% |
| 2024-08-09 | 2024-08-09 | Dividend | ₹ 2.00 /share | 12.01% |
| 2024-03-12 | 2024-03-12 | Extraordinary General Meeting | NA | -11.30% |
| 2023-07-04 | 2023-06-30 | Dividend | ₹ 2.00 /share | 12.03% |
| 2022-06-23 | 2022-06-25 | Dividend | ₹ 2.00 /share | -16.63% |
| 2021-08-18 | 2021-08-22 | Dividend | ₹ 2.00 /share | -24.60% |
Nath Bio-Genes Competitors Screener - Peer Comparison
Screen NATHBIOGEN competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| LT Foods | 14,076 | 22.01 | 10,946 | 24.81% | 613 | 46.55 |
| KRBL | 8,192 | 12.16 | 6,098 | 7.83% | 641 | 54.21 |
| Gujarat Ambuja Exports | 7,475 | 24.62 | 5,729 | 22.01% | 311 | 58.69 |
| Kaveri Seed Company | 4,750 | 15.67 | 1,251 | 3.28% | 282 | 47.72 |
| Trualt Bioenergy | 4,152 | 28.75 | 1,728 | -12.24% | 127 | 58.60 |
| GRM Overseas | 2,896 | 45.85 | 1,374 | 2.17% | 61 | 39.66 |
| Sanstar | 1,895 | 31.85 | 1,082 | -10.58% | 67 | 56.96 |
| Chaman Lal Setia Exports | 1,482 | 13.13 | 1,504 | 10.16% | 103 | 63.76 |
| Gulshan Polyols | 1,119 | 27.63 | 2,025 | 45.63% | 25 | 46.20 |
| Avt Natural Products | 1,056 | 18.03 | 572 | 8.00% | 48 | 60.26 |
Nath Bio-Genes Company Announcements - News Screener
Screen NATHBIOGEN latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-05-11 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2026-05-11 | NBIL Concall | - |
| 2026-05-11 | Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A | - |
| 2026-05-04 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-05-04 | Board Meeting Outcome for Outcome Of Board Meeting | - |
| 2026-05-04 | Outcome Of Board Meeting | - |
| 2026-04-29 | Intimation Of Conference Call | - |
| 2026-04-25 | Board Meeting Intimation for Approval Of Financial Results As On 31St March 2026. | - |
| 2026-04-16 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-03-26 | Closure of Trading Window | - |
| 2026-01-31 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-01-31 | Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate | - |
| 2026-01-31 | Outcome Of Board Meeting | - |
| 2026-01-24 | Board Meeting Intimation for Approval Of Financial Results As On 31St December 2025. | - |
| 2026-01-20 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-01-13 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2025-12-27 | Closure of Trading Window | - |
| 2025-11-18 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2025-11-14 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2025-11-13 | Financial Results As On 30Th September 2025 | - |